XLRN : Acceleron Pharma stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2021-03-18 |
|---|---|---|---|---|
| 2022 | $148.36 | $137.76 | $158.24 | 11.07% |
| 2023 | $165.59 | $160.71 | $174.82 | 23.96% |
| 2024 | $185.92 | $177.1 | $194.36 | 39.18% |
| 2025 | $217.96 | $196.87 | $229.29 | 63.17% |
| 2026 | $233.59 | $225.52 | $244.04 | 74.87% |
| 2027 | $244.92 | $244.25 | $245.27 | 83.35% |
| 2028 | $241.72 | $238.35 | $244.02 | 80.95% |
| 2029 | $229.04 | $214.66 | $237.43 | 71.46% |
| 2030 | $170.91 | $150.89 | $210.66 | 27.95% |
| 2031 | $125.72 | $106.71 | $148.22 | -5.88% |
| 2032 | $104.05 | $102.81 | $105.31 | -22.1% |
From AI system, total return is 2947.45% from 3364 forecasts.
For Acceleron Pharma stock forecast for 2022, 9 predictions are offered for each month of 2022 with average Acceleron Pharma stock
forecast of $148.36, a high forecast of $158.24, and a low forecast of $137.76.
The average Acceleron Pharma stock forecast 2022 represents a 11.07%
increase from the last price of $133.58.
For Acceleron Pharma stock forecast for 2023, 12 predictions are offered for each month of 2023 with average Acceleron Pharma stock
forecast of $165.59, a high forecast of $174.82, and a low forecast of $160.71.
The average Acceleron Pharma stock forecast 2023 represents a 23.96%
increase from the last price of $133.58.
For Acceleron Pharma stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Acceleron Pharma stock
forecast of $217.96, a high forecast of $229.29, and a low forecast of $196.87.
The average Acceleron Pharma stock forecast 2025 represents a 63.17%
increase from the last price of $133.58.
For Acceleron Pharma stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average Acceleron Pharma stock
forecast of $244.92, a high forecast of $245.27, and a low forecast of $244.25.
The average Acceleron Pharma stock forecast 2027 represents a 83.35%
increase from the last price of $133.58.
For Acceleron Pharma stock forecast for 2030, 12 predictions are offered for each month of 2030 with average Acceleron Pharma stock
forecast of $170.91, a high forecast of $210.66, and a low forecast of $150.89.
The average Acceleron Pharma stock forecast 2030 represents a 27.95%
increase from the last price of $133.58.
For Acceleron Pharma stock forecast for 2032 (10 year), 3 predictions are offered for each month of 2032 with average Acceleron Pharma stock
forecast of $104.05, a high forecast of $105.31, and a low forecast of $102.81.
The average Acceleron Pharma stock forecast 2032 represents a -22.1%
decrease from the last price of $133.58.
Please, see more forecasts below.
XLRN : Acceleron Pharma stock forecast by Wall Street Analysts
Acceleron Pharma stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2021-03-19 | $133.15 | -0.32% |
| 2021-03-22 | $136.08 | 2.20% |
| 2021-03-23 | $140.94 | 3.57% |
| 2021-03-24 | $140.54 | -0.28% |
| 2021-03-25 | $138.88 | -1.18% |
XLRN : Long term Acceleron Pharma stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2022 Apr. is $137.76 , for 2023 Mar. is $162.04 , for 2026 Mar. is $226.36 , for 2027 Mar. is $245.27 , for 2031 Mar. is $141.01 , and for 2032 Mar. is $102.81.
XLRN : Acceleron Pharma stock forecast for 2022
| Date | Price Target | Change |
|---|---|---|
| 2022 Apr. | $137.76 | 3.13% |
| 2022 May. | $140.30 | 1.85% |
| 2022 Jun. | $142.33 | 1.45% |
| 2022 Jul. | $146.38 | 2.85% |
| 2022 Aug. | $149.24 | 1.95% |
| 2022 Sep. | $151.62 | 1.59% |
| 2022 Oct. | $153.80 | 1.44% |
| 2022 Nov. | $155.59 | 1.16% |
| 2022 Dec. | $158.24 | 1.70% |
XLRN : Acceleron Pharma stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jan. | $160.71 | 1.56% |
| 2023 Feb. | $161.84 | 0.70% |
| 2023 Mar. | $162.04 | 0.13% |
| 2023 Apr. | $162.29 | 0.15% |
| 2023 May. | $162.29 | -0.00% |
| 2023 Jun. | $162.51 | 0.14% |
| 2023 Jul. | $162.82 | 0.19% |
| 2023 Aug. | $164.46 | 1.00% |
| 2023 Sep. | $168.95 | 2.73% |
| 2023 Oct. | $171.22 | 1.34% |
| 2023 Nov. | $173.08 | 1.09% |
| 2023 Dec. | $174.82 | 1.00% |
XLRN : Acceleron Pharma stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $177.10 | 1.31% |
| 2024 Feb. | $179.28 | 1.23% |
| 2024 Mar. | $180.79 | 0.84% |
| 2024 Apr. | $183.38 | 1.43% |
| 2024 May. | $184.30 | 0.50% |
| 2024 Jun. | $185.17 | 0.47% |
| 2024 Jul. | $186.53 | 0.74% |
| 2024 Aug. | $187.76 | 0.66% |
| 2024 Sep. | $189.12 | 0.72% |
| 2024 Oct. | $190.79 | 0.88% |
| 2024 Nov. | $192.41 | 0.85% |
| 2024 Dec. | $194.36 | 1.02% |
XLRN : Acceleron Pharma stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $196.87 | 1.29% |
| 2025 Feb. | $200.32 | 1.76% |
| 2025 Mar. | $204.63 | 2.15% |
| 2025 Apr. | $210.35 | 2.80% |
| 2025 May. | $214.97 | 2.19% |
| 2025 Jun. | $219.85 | 2.27% |
| 2025 Jul. | $224.64 | 2.18% |
| 2025 Aug. | $228.04 | 1.51% |
| 2025 Sep. | $229.22 | 0.52% |
| 2025 Oct. | $229.29 | 0.03% |
| 2025 Nov. | $228.98 | -0.13% |
| 2025 Dec. | $228.38 | -0.26% |
XLRN : Acceleron Pharma stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $226.72 | -0.73% |
| 2026 Feb. | $225.52 | -0.53% |
| 2026 Mar. | $226.36 | 0.37% |
| 2026 Apr. | $228.06 | 0.75% |
| 2026 May. | $228.88 | 0.36% |
| 2026 Jun. | $230.55 | 0.73% |
| 2026 Jul. | $233.10 | 1.11% |
| 2026 Aug. | $236.15 | 1.31% |
| 2026 Sep. | $239.14 | 1.26% |
| 2026 Oct. | $241.48 | 0.98% |
| 2026 Nov. | $243.08 | 0.66% |
| 2026 Dec. | $244.04 | 0.40% |
XLRN : Acceleron Pharma stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $244.61 | 0.23% |
| 2027 Feb. | $245.04 | 0.18% |
| 2027 Mar. | $245.27 | 0.09% |
| 2027 Apr. | $245.27 | 0.00% |
| 2027 May. | $245.13 | -0.06% |
| 2027 Jun. | $245.08 | -0.02% |
| 2027 Jul. | $245.16 | 0.04% |
| 2027 Aug. | $245.12 | -0.02% |
| 2027 Sep. | $244.92 | -0.08% |
| 2027 Oct. | $244.73 | -0.08% |
| 2027 Nov. | $244.50 | -0.09% |
| 2027 Dec. | $244.25 | -0.10% |
XLRN : Acceleron Pharma stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $244.02 | -0.10% |
| 2028 Feb. | $243.79 | -0.09% |
| 2028 Mar. | $243.55 | -0.10% |
| 2028 Apr. | $243.24 | -0.13% |
| 2028 May. | $242.79 | -0.18% |
| 2028 Jun. | $242.29 | -0.21% |
| 2028 Jul. | $241.77 | -0.22% |
| 2028 Aug. | $241.19 | -0.24% |
| 2028 Sep. | $240.57 | -0.26% |
| 2028 Oct. | $239.91 | -0.28% |
| 2028 Nov. | $239.17 | -0.31% |
| 2028 Dec. | $238.35 | -0.34% |
XLRN : Acceleron Pharma stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $237.43 | -0.39% |
| 2029 Feb. | $236.41 | -0.43% |
| 2029 Mar. | $235.29 | -0.47% |
| 2029 Apr. | $234.07 | -0.52% |
| 2029 May. | $232.74 | -0.57% |
| 2029 Jun. | $231.30 | -0.62% |
| 2029 Jul. | $229.74 | -0.67% |
| 2029 Aug. | $228.01 | -0.75% |
| 2029 Sep. | $225.95 | -0.90% |
| 2029 Oct. | $223.28 | -1.18% |
| 2029 Nov. | $219.62 | -1.64% |
| 2029 Dec. | $214.66 | -2.26% |
XLRN : Acceleron Pharma stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $210.66 | -1.86% |
| 2030 Feb. | $203.84 | -3.24% |
| 2030 Mar. | $195.17 | -4.26% |
| 2030 Apr. | $184.67 | -5.38% |
| 2030 May. | $173.41 | -6.10% |
| 2030 Jun. | $163.50 | -5.71% |
| 2030 Jul. | $156.80 | -4.10% |
| 2030 Aug. | $153.66 | -2.00% |
| 2030 Sep. | $152.91 | -0.49% |
| 2030 Oct. | $152.94 | 0.02% |
| 2030 Nov. | $152.48 | -0.31% |
| 2030 Dec. | $150.89 | -1.04% |
XLRN : Acceleron Pharma stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $148.22 | -1.77% |
| 2031 Feb. | $144.86 | -2.27% |
| 2031 Mar. | $141.01 | -2.66% |
| 2031 Apr. | $136.75 | -3.02% |
| 2031 May. | $132.12 | -3.39% |
| 2031 Jun. | $127.14 | -3.77% |
| 2031 Jul. | $122.05 | -4.00% |
| 2031 Aug. | $117.37 | -3.83% |
| 2031 Sep. | $113.52 | -3.29% |
| 2031 Oct. | $110.57 | -2.60% |
| 2031 Nov. | $108.38 | -1.98% |
| 2031 Dec. | $106.71 | -1.54% |
XLRN : Acceleron Pharma stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $105.31 | -1.30% |
| 2032 Feb. | $104.04 | -1.21% |
| 2032 Mar. | $102.81 | -1.18% |
Financial Data for Acceleron Pharma stock
Frequently Asked Questions about Acceleron Pharma stock forecast
Is Acceleron Pharma a good long term stock?
From Acceleron Pharma stock forecast , Acceleron Pharma (XLRN) stock can be a good investment choice. According to AI Pickup, the Acceleron Pharma stock price forecast for 2022 Apr. is $137.759502431568 From Acceleron Pharma stock forecast , Acceleron Pharma (XLRN) stock can be a good investment choice. According to AI Pickup, the Acceleron Pharma stock price forecast for 2023 Mar. is $162.043673136324 From Acceleron Pharma stock forecast , Acceleron Pharma (XLRN) stock can be a good investment choice. According to AI Pickup, the Acceleron Pharma stock price forecast for 2026 Mar. is $226.362116523117 From Acceleron Pharma stock forecast , Acceleron Pharma (XLRN) stock can be a good investment choice. According to AI Pickup, the Acceleron Pharma stock price forecast for 2027 Mar. is $245.270599937866 From Acceleron Pharma stock forecast , Acceleron Pharma (XLRN) stock can be a good investment choice. According to AI Pickup, the Acceleron Pharma stock price forecast for 2031 Mar. is $141.008144125914 From Acceleron Pharma stock forecast , Acceleron Pharma (XLRN) stock cannot be a good investment choice. According to AI Pickup, the Acceleron Pharma stock price forecast for 2032 Mar. is $102.808971744703
Is Acceleron Pharma stock overvalued?
Acceleron Pharma (XLRN) stock is expected to go UP . Therefore, AI Pickup would say that Acceleron Pharma (XLRN) stock is NOT overvalued.
Will Acceleron Pharma stock price go up?
Yes. The Acceleron Pharma stock price forecast for 2023 Mar. is $162.043673136324
Is Acceleron Pharma stock a good buy now?
Since closing price on 2021-03-18 is $133.58 and forecast for 2023 Mar. is $162.04, Acceleron Pharma stock is a good 1 year investment.